ALFA Filings
Every announcement, straight from the exchange
Every Clinitech Laboratory other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Clinitech Laboratory submitted a certificate confirming the non-applicability of SEBI Regulation 23 regarding Related Party Transactions. This is for the half-year ended September 30, 2026.
Clinitech Laboratory Limited filed a Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming no rematerialization requests were received.
Clinitech Laboratory Limited submitted an undertaking regarding the non-applicability of Related Party Transaction disclosures for the period ended March 31, 2026. The company is exempt under SEBI LODR Regulation 15 as it is listed on the BSE SME portal and does not exceed the specified threshold limits.
Clinitech Laboratory Limited submitted an undertaking regarding the non-applicability of the Annual Secretarial Compliance Report for the year ended March 31, 2026. As an SME-listed entity on the BSE, the company is exempt from this requirement under Regulation 15(2) of SEBI (LODR) Regulations, 2015.
Clinitech Laboratory Limited submitted a compliance certificate for the quarter ended March 31, 2026. The Registrar and Transfer Agent, Bigshare Services, confirmed that all shares remain in dematerialized form and no rematerialisation requests were received during the period.